Atossa Therapeutics Presents Clinical Trial Update Highlighting (Z)-Endoxifen Research at the 2026 MDA Clinical & Scientific Conference

Go back to Atossa Therapeutics Presents Clinical Trial Update Highlighting (Z)-Endoxifen Research at the 2026 MDA Clinical & Scientific Conference
ATOSSA GNTCS (NASDAQ: ATOS) Delayed: 2.12 +0.08 (3.92%)
Previous Close $2.04    52 Week High $3.64 
Open $2.03    52 Week Low $0.14 
Day High $2.19    P/E N/A 
Day Low $2.03    EPS $0.00 
Volume 116,528